1. In partnership with the actress and caregiver, the brand kicks off CareWalks, a pledge to caregivers across the country that offers resources and encourages movement through a new video series, a charitable donation and more

    WARREN, N.J., May 4, 2022 /PRNewswire/ -- 1 in 5 Americans provide care to family members or loved ones,1 a task that's inherently connected with physical pain. With many caregivers also dealing with the added challenges of experiencing joint pain, GSK Consumer Healthcare (NYSE:GSK) today announced Voltaren Arthritis Pain Gel is partnering with actress and caregiver Jennie Garth for the launch of CareWalks, an initiative dedicated to those who care for others.

    Data shows 94% of caregivers nationwide…

    View Full Article
  2. MOBItalks is back and ready to empower attendees with conversation around alternative wellness, understanding sex therapy, and black queer joy with industry leaders and community activists.

    NEW YORK, May 2, 2022 /PRNewswire/ -- Mobilizing Our Brothers Initiative (MOBI) is teaming up with local New York-based Entertainers, Entrepreneurs and Community Based Leaders for their signature MOBItalks presented by ViiV Healthcare accelerate initiative. MOBItalks, a free personal and professional development series for Black gay men, creates distinguished experiences while encouraging attendees to live stronger, longer, and healthier.

    MOBI is excited to return where it all started with MOBItalks. MOBItalks New York will take place on May 14th at 265 West…

    View Full Article
    • Sierra Oncology's differentiated momelotinib has the potential to address the critical unmet medical needs of myelofibrosis patients with anaemia
    • Momelotinib complements GSK's existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
    • Sales contribution expected to start in 2023 with significant growth potential thereafter
    • Supports development of strong portfolio of new specialty medicines and vaccines

    GlaxoSmithKline plc (NYSE:GSK) and Sierra Oncology, Inc (NASDAQ:SRRA) today announced that the companies have entered into an agreement under which GSK will acquire Sierra Oncology, a California-based, late-stage biopharmaceutical company…

    View Full Article
    • Analysis of data collected between March 2020–February 2021 from nearly 2 million Americans indicates patients diagnosed with COVID-19 may be more likely to develop shingles in the six months following diagnosis
    • Observed effect was higher for patients with severe cases of COVID-19 who required hospitalization

    According to a new study conducted by GSK, people age 50 or older in the US who have had COVID-19 may be at greater risk of developing shingles – a painful rash – compared to those who haven't been diagnosed with COVID-19. This research was published in the Infectious Diseases Society of America's Open Forum Infectious Diseases.

    Key findings include:

    • In this retrospective cohort study, people aged 50 or older who contracted COVID-19…
    View Full Article
  3. JERUSALEM, March 28, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative products for the prevention and treatment of infectious diseases and other illnesses, today published its fourth quarter and full year financial results for the year ended December 31, 2021 and provided a business update. At the same time, the Company filed its Annual Report on Form 20-F with the Securities and Exchange Commission.

    BiondVax_Pharmaceuticals_Logo

    Business Update

    • BiondVax signed an exclusive license agreement for the development and commercialization of a COVID–19 innovative nanosized antibody (NanoAbs) therapy in December 2021 with the Max Planck Institute for Multidisciplinary…
    View Full Article